4-Acetyl-2-methoxyphenyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside(CAS: 38784-73-5)

CAS号
相关产品
2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
CAS号: 34620-78-5
其他供应商提供的 4-Acetyl-2-methoxyphenyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
基本信息
分子式
C21H30O13
分子量
490.46 g/mol
物理状态
Powder
化学标识符
SMILES
CC(=O)c1ccc(c(c1)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O
InChIKey
QDJKYPXSGCCOCT-LWZURRPWSA-N
数据库引用
常见问题
Tectoruside是一种白色结晶性粉末,分子量为522.27。它在水中溶解度较低,但在乙醇和甲醇中有较好的溶解性。Tectoruside具有一定的反应活性,可以参与多种化学反应,如酯交换反应和糖苷水解反应。
Tectoruside可以通过糖苷合成方法合成。常见的合成路线是从4-甲氧基苯酚出发,首先与乙酸反应生成乙酸酯,然后在酸性条件下与葡萄糖苷反应生成Tectoruside。该合成路线的产率约为75%。
Tectoruside在医药行业中用于制备药物,特别是在抗炎和抗过敏药物的开发中。此外,它在保健品行业也有应用,作为天然抗氧化剂。
在处理Tectoruside时,应佩戴合适的个人防护装备(PPE),如实验室外套、手套、护目镜等。操作时应在通风橱中进行,以避免吸入有害气体。如果发生泄漏,应立即用大量水冲洗并清理。参考安全数据表(SDS)以获取详细的安全信息。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序


![4-{(1R,3aS,4R,6aS)-4-[4-(beta-D-Glucopyranosyloxy)-3,5-dimethoxyphenyl]tetrahydro-1H,3H-furo[3,4-c]furan-1-yl}-2,6-dimethoxyphenyl beta-D-glucopyranoside](https://cnstatic.chemtradehub.com/structs/667/66791-77-3-74b7.webp)


![2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol](https://cnstatic.chemtradehub.com/structs/346/34620-78-5-d616.webp)

![2-(3,4-Dihydroxy-5-methoxyphenyl)-5-(beta-D-glucopyranosyloxy)-7-hydroxy-3-chromeniumyl 6-O-{6-deoxy-4-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-alpha-L-mannopyranosyl}-beta-D-glucopyranoside chloride](https://cnstatic.chemtradehub.com/structs/699/69915-09-9-afab.webp)






